270 related articles for article (PubMed ID: 25880156)
1. Photoinduced aggregation of a model antibody-drug conjugate.
Cockrell GM; Wolfe MS; Wolfe JL; Schöneich C
Mol Pharm; 2015 Jun; 12(6):1784-97. PubMed ID: 25880156
[TBL] [Abstract][Full Text] [Related]
2. Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol.
Mohamed HE; Mohamed AA; Al-Ghobashy MA; Fathalla FA; Abbas SS
J Pharm Biomed Anal; 2018 Feb; 150():268-277. PubMed ID: 29258046
[TBL] [Abstract][Full Text] [Related]
3. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
Pan LY; Salas-Solano O; Valliere-Douglass JF
Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
[TBL] [Abstract][Full Text] [Related]
4. Distinctive Low-Resolution Structural Features of Dimers of Antibody-Drug Conjugates and Parent Antibody Determined by Small-Angle X-ray Scattering.
Law-Hine D; Rudiuk S; Bonestebe A; Ienco R; Huille S; Tribet C
Mol Pharm; 2019 Dec; 16(12):4902-4912. PubMed ID: 31618040
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes.
Wakankar AA; Feeney MB; Rivera J; Chen Y; Kim M; Sharma VK; Wang YJ
Bioconjug Chem; 2010 Sep; 21(9):1588-95. PubMed ID: 20698491
[TBL] [Abstract][Full Text] [Related]
6. Analyzing protein conjugation reactions for antibody-drug conjugate synthesis using polarized excitation emission matrix spectroscopy.
de Faria E Silva AL; Ryder AG
Biotechnol Bioeng; 2022 Dec; 119(12):3432-3446. PubMed ID: 36071600
[TBL] [Abstract][Full Text] [Related]
7. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
[TBL] [Abstract][Full Text] [Related]
8. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
[TBL] [Abstract][Full Text] [Related]
9. Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate.
Luo Q; Chung HH; Borths C; Janson M; Wen J; Joubert MK; Wypych J
Anal Chem; 2016 Jan; 88(1):695-702. PubMed ID: 26629796
[TBL] [Abstract][Full Text] [Related]
10. Investigation of High Molecular Weight Size Variant Formation in Antibody-Drug Conjugates: Microbial Transglutaminase-Mediated Crosslinking.
Zhao Y; Kim S; Zheng X; Kim SH; Han A; Chen TH; Wang S; Zhong J; Qiu H; Li N
J Pharm Sci; 2023 Oct; 112(10):2629-2636. PubMed ID: 37586591
[TBL] [Abstract][Full Text] [Related]
11. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
[TBL] [Abstract][Full Text] [Related]
12. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.
Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD
J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
14. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.
Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y
AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of Antibody Drug Conjugates at Room Temperature: SAXS and Light Scattering Evidence for Colloidal Instability of a Specific Subpopulation.
Frka-Petesic B; Zanchi D; Martin N; Carayon S; Huille S; Tribet C
Langmuir; 2016 May; 32(19):4848-61. PubMed ID: 27129612
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.
Glover ZK; Wecksler A; Aryal B; Mehta S; Pegues M; Chan W; Lehtimaki M; Luo A; Sreedhara A; Rao VA
MAbs; 2022; 14(1):2122957. PubMed ID: 36151884
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
[TBL] [Abstract][Full Text] [Related]
18. SEC-MS in denaturing conditions (dSEC-MS) for in-depth analysis of rebridged monoclonal antibody-based formats.
Benazza R; Koutsopetras I; Vaur V; Chaubet G; Hernandez-Alba O; Cianférani S
Talanta; 2024 May; 272():125727. PubMed ID: 38364570
[TBL] [Abstract][Full Text] [Related]
19. Quantitative collision-induced unfolding differentiates model antibody-drug conjugates.
Tian Y; Lippens JL; Netirojjanakul C; Campuzano IDG; Ruotolo BT
Protein Sci; 2019 Mar; 28(3):598-608. PubMed ID: 30499138
[TBL] [Abstract][Full Text] [Related]
20. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]